Skip to main content
PLOS One logoLink to PLOS One
. 2024 Feb 26;19(2):e0298537. doi: 10.1371/journal.pone.0298537

Efficacy and safety of auricular therapy in the treatment of post-stroke constipation: A protocol for systematic review and meta-analysis

Chunyu Ma 1,#, Ping Niu 2,#, Huifang Guan 1, Ziqiao Yu 2, Qiaoli Xu 2, Junchao Yu 2, Jing Su 1, Dexi Zhao 2,*
Editor: Md Shahjalal3
PMCID: PMC10896502  PMID: 38408100

Abstract

Background

Constipation is one of the common gastrointestinal complications after stroke. It not only aggravates the condition of stroke, but also brings huge medical burden to patients, and has a negative impact on the quality of life of patients. Auricular therapy, as a part of Chinese traditional acupuncture and moxibustion, has been found to be effective in the clinical treatment of constipation. However, no systematic review has investigated the efficacy and safety of auricular therapy in the treatment of post-stroke constipation. Therefore, the aim of this systematic review is to assess the effectiveness and safety of auricular therapy for post-stroke constipation.

Methods and analysis

Eight electronic databases including PubMed, Cochrane Library/Cochrane Central Register of Controlled Trials, Web of Science, Embase, China National Knowledge Internet, Chinese Biomedical Literature Database, Wanfang, and VIP databases, will be searched for relevant studies published from inception to February 2023. Two reviewers will independently conduct research selection, data extraction, and evaluation of research quality. Only randomized controlled trials (RCTs) that assess the efficacy and safety of auricular therapy for the treatment of post-stroke constipation will be included in this study. We will use the Cochrane risk of bias assessment tool to evaluate the methodological qualities (including bias risk). If possible, a meta-analysis will be performed after screening.

Results

This study may provide high-quality evidence for the efficacy and safety of auricular therapy in treating post-stroke constipation.

Conclusion

The conclusions of our study will provide an evidence to judge whether auricular therapy is an effective and safe intervention for patients with post-stroke constipation.

Ethics and dissemination

Ethical approval is not required, as this study was based on a review of published research. This review will be published in a peer-reviewed journal and disseminated electronically and in print.

Trial registration

Registration number: PROSPERO CRD42023402242.

1. Introduction

In recent years, with the acceleration of social aging, as well as changes in lifestyle and other factors, the incidence rate of stroke has gradually increased, and the age of onset is younger [1]. It is reported that as one of the more common and very serious complications after stroke in clinical practice, the incidence of post-stroke constipation is 22.9%– 79% [2, 3]. Post-stroke constipation can cause varying degrees of harm to stroke patients, ranging from mild symptoms such as abdominal pain and bloating to severe symptoms such as intestinal obstruction due to constipation. In addition, potential hazards of constipation include: The long-term accumulation of feces in the intestinal tract can decompose endotoxin and be reabsorbed by the body, thereby aggravating the damage to other systems and even the central nervous system of the body; During forced defecation, the pressure in the abdominal cavity increases, which can induce hypertension and even lead to another stroke; Aggravate the brain nerve damage at the lesion site [4], affecting the prognosis of patients [5, 6]; Patients with post-stroke constipation often experience discomfort due to constipation symptoms, often accompanied by abnormal emotions such as anxiety and depression [7]. These seriously affect the quality of life of patients. Therefore, post-stroke constipation is a problem that needs attention and urgent solution. To explore an effective treatment plan for post-stroke constipation is not only an effective treatment for the symptom of constipation, but also has a promoting effect on the recovery of stroke and the cutoff of complications.

Clinically, commonly used methods for treating constipation include colon motility drugs, irritant/volumetric/permeable/softening/lubricating laxatives, or retention enemas. Although these drugs or external treatment methods can immediately and effectively excrete stool, it is difficult to maintain the efficacy after stopping the drug. Taking them for a long time or having toxic side effects on the body or forming drug dependence cannot effectively solve the problem of constipation in patients after stroke [8]. Traditional Chinese medicine technology has a unique and significant effect in the prevention and treatment of constipation symptoms after stroke. Whether it is oral administration of Chinese medicine or acupuncture and moxibustion therapy, from clinical literature reports, it can be seen that it has a good improvement effect on constipation after stroke, and does not have adverse reactions such as drug dependence. Therefore, searching for an effective treatment for post-stroke constipation from traditional therapies is a way to explore the treatment of post-stroke constipation in clinical practice.

Auricular therapy is an important part of Chinese traditional acupuncture, which refers to a traditional external treatment of Chinese medicine by sticking medicine beans or magnetic beads on ear points and pressing and stimulating ear points to make them feel sour, numb, swollen, etc. In recent decades, auricular therapy has been continuously improved while inheriting traditional auricular therapy, and has been widely applied in clinical disease treatment systems [9]. Therefore, this study intends to conduct a meta-analysis of the study of auricular therapy for post-stroke constipation, to explore its efficacy and safety, in order to provide reliable evidence for the clinical application of auricular therapy.

2. Methods

2.1. Study registration and ethics

The protocol of the present study adhered to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis Protocol (S1 Appendix) guidelines and checklist [10] and the protocol is registered on PROSPERO under the registration number(CRD42023402242). The data for this study will be obtained from the published literature, and no ethical approval will be required for this systematic review.

2.2. Eligible criteria for study selection

2.2.1. Types of studies

All of the RCTs reporting the use of auricular therapy for the treatment of constipation in stroke patients should be included in this study. There are no restrictions on publishing status or language. Quasi-RCTs, non-RCTs, case reports, case series, non controlled trials, cross trials, reviews, observational study of clinical cases and animal studies will be excluded. If the studies fails to provide detailed results, it will also be excluded.

2.2.2. Types of participants

The subjects included in the study should meet various diagnostic criteria for cerebrovascular diseases. At the same time, symptoms of constipation should also be met. The diagnosis was based on the Rome II/III diagnostic criteria or the Chinese herbal medicine clinical research guide. There are no age, nationality, or race restrictions for the participants included in the study. However, clinical studies on subdural or subarachnoid hemorrhage, patients with a history of constipation or gastrointestinal disease or surgical history prior to stroke, auricular therapy as an adjuvant treatment, and studies with unclear diagnostic criteria will be excluded.

2.2.3. Types of interventions

Research using auricular therapy (Auricular therapy is a method for treating by stimulating a specific point in the ear, including medicine beans or magnetic beads, acupuncture, electroacupuncture, acupressure, drug injection, electric pulse stimulation, moxibustion, auricle bloodletting, etc.) or auricular therapy combined with other therapies(Western medicine, Chinese medicine/Chinese patent medicine, non-drug therapy, etc.). There are no restrictions on the acupoints and treatment courses in the study.

2.2.4. Types of outcome measures

For the primary outcome, we will assess the frequency of spontaneous defecation, defined as the mean number of spontaneous defecations per week. Secondary outcome measures include proportion of patients with defecation time, interval between bowel movements, number of bowel movements, changes in stool characteristics, etc. In addition, it is necessary to observe whether there are any adverse reactions during the treatment period.

2.3. Search strategies for the identification of studies

We will perform a comprehensive search using in PubMed, Cochrane Library/Cochrane Central Register of Controlled Trials, Web of Science, Embase, and four Chinese databases (China National Knowledge Internet, Chinese Biomedical Literature Database, Wanfang, and VIP databases). "Post-stroke constipation", "auricular therapy" and "Randomized clinical trials" as the key words or free-text terms. There are no restrictions of countries, population characteristics, language. The specific search strategies (for example, PubMed) are listed in Table 1. We will make relative modifications in accordance with the requirements, and an equivalent translation of the search terms will be adopted to ensure that similar search terms are used in all databases. If additional information is needed from the identified studies, we will contact the corresponding authors.

Table 1. The search strategy for PubMed.

Order Strategy
#1 Search: “Stroke”[Mesh]
#2 Search: “Strokes”[Title/Abstract] OR “Cerebrovascular Accident”[Title/Abstract] OR
“Brain Vascular Accident”[Title/Abstract] OR “Cerebrovascular Stroke”[Title/Abstract]
OR “Apoplexy”[Title/Abstract] OR “Cerebral Stroke”[Title/Abstract]
#3 #1 OR #2
#4 Search: “Constipation”[Mesh]
#5 Search: “Constipation”[Title/Abstract] OR “Constipated”[Title/Abstract] OR
“Constipating“[Title/Abstract] OR “Constipations“[Title/Abstract]
#6 #4 OR #5
#7 Search: “auricular”[Title/Abstract] OR “auricular therapy”[Title/Abstract] OR
“auricular acupuncture”[Title/Abstract] OR “auricular acupoints”[Title/Abstract] OR
“auricular point sticking”[Title/Abstract] OR “electric pulse stimulation”[Title/Abstract] OR
“auricular massage”[Title/Abstract] OR “auricular bleed”[Title/Abstract]
#8 Search: “randomized controlled trial”[Publication Type] OR “RCT randomized controlled”
[Publication Type] OR “random allocation”[Title/Abstract] OR “allocation,random”
[Title/Abstract] OR “randomized, controlled”[Title/Abstract] OR “clinical trial”
[Title/Abstract]
#9 Search: “humans”[MeSH Terms] NOT “animals”[MeSH Terms]
#10 #8 AND #9
#11 #3 AND #6 AND #7 AND #10

2.4. Data collection and analysis

2.4.1. Data extraction and management

  1. The literature search was performed independently by two authors (Chunyu Ma and Huifang Guan) through the database mentioned above.

  2. The information of eligible study will be double-checked by two reviewers (Chunyu Ma and Huifang Guan) again. In case of disagreement on the suitability of a study for inclusion between the reviewers at this stage, the article will be checked by the other reviewer (Ziqiao Yu) again.

All studies identified through electronic and manual searches will be uploaded to EndNote 20 (Clarate Analytics). After deleting duplicates (the reasons for excluding the study will be recorded), a full text review of the included studies will be conducted. The above process is shown in the flowchart, as shown in Fig 1.

Fig 1. Flow diagram of study selection process.

Fig 1

The information of screened studies will be extracted independently by two reviewers(Chunyu Ma and Huifang Guan). The data extraction content mainly includes:1. Basic information included in the research; 2. Baseline characteristics of the study subjects; 3. Specific details of interventions, comparison, follow-up time, etc.; 4. Key elements of risk assessment for bias; 5. Outcome indicators and outcome measurement data. In case of any disagreement on data extraction, it will be evaluated by the third reviewer (Ziqiao Yu). If there are unclear data, we will contact the corresponding author and gather relevant information.

2.4.2. Assessment of bias risk and quality of included studies

Two reviewers (Chunyu Ma and Huifang Guan) evaluated the bias risk of inclusion in the study according to the Cochrane Handbook 5. 1. 0 for RCT bias risk assessment tools [11], including random sequence generation, allocation concealment, blinding of patients and trial personnel, outcome assessors, outcome data completeness, selective reporting, other bias (declare fraud, potential bias related to the special study design, etc.). The risk of bias of the included literature was finally divided into three grades: "low", "high" and "unclear". If there is a disagreement, the discussion is resolved or judged by a third reviewer (Ziqiao Yu).

2.4.3. Measurement of treatment effect

Continuous variables were mainly measured by mean difference (MD) and 95% confidence intervals (CI), while dichotomous variables were measured by relative risk(RR) (or odds ratios(OR)) and 95%CI.

2.4.4. Assessment of heterogeneity

All statistical analyses will be performed by the Cochrane Collaboration Review Manager software (RevMan 5.3). P<0.05 indicates statistical significance. The heterogeneity among the results of the included literature was analyzed by χ2 test (α = 0.1), and the heterogeneity was quantitatively determined by I2. When I2 50%, it indicates no statistical heterogeneity or little heterogeneity, using fixed effects model for analysis; when I2> 50%, analyze the source of heterogeneity, the subgroups of factors, analysis or sensitivity analysis may cause heterogeneity analysis; if the included literature have statistical heterogeneity, sex without clinical heterogeneity, the random effects model was used for combined analysis. When 10 studies were included for an outcome measure, funnel plots were used to observe publication bias. We will use the Grading of Recommendations Assessment, Development and Evaluation (GRADE) pro software from Cochrane Systematic Reviews to create a Summary of Findings table.

2.4.5. Subgroup analysis

We will perform the following subgroup analysis to study heterogeneity when there is sufficient data. We will perform subgroup analysis based on age, gender, type of stroke (hemorrhagic and ischemic stroke), different definitions of constipation, stages of stroke (acute, subacute or chronic), and controls Type of group (placebo, no treatment or other active treatment or medication). A subgroup analysis based on different dietary groups takes into account that eating habits may play a role, and habits are playing an important role in the development of constipation. The intervention effect was analyzed using the χ2 test, with p<0.05, indicating a statistically significant difference between the subgroups.

2.4.6. Sensitivity analysis

We will perform a sensitivity analysis to verify the robustness of the results.

If the quality of the study is judged to be low (after evaluating the sample size, missing data, and the impact of the selected model), these studies will be deleted.

2.4.7. Ethics and dissemination

A formal ethical approval was not required for this protocol. The results of this review will be disseminated to peer-reviewed journals or presented at a relevant conference.

3. Discussion

Studies have shown that there is a strong correlation between brain function and the occurrence of constipation due to the interaction between the central nervous system and the intestinal autonomic nervous system [12]. During the onset and recovery of stroke, patients may experience abnormal intestinal activity, impaired anorectal and colonic sensory function, decreased control of internal and external sphincters, and subsequent neurogenic intestinal dysfunction due to factors such as the impact of stroke lesion sites on defecation in the central nervous system, long-term bed rest with hemiplegia, irregular defecation posture during recovery, and changes in dietary structure. This can lead to a high incidence of constipation after stroke. The treatment of post-stroke constipation in modern medicine cannot effectively solve the problem of post-stroke constipation in patients. In recent years, several clinical studies have reported that auricular therapy has shown good efficacy in the treatment of chronic constipation, and there is a trend to replace drugs in the treatment of chronic constipation. It has the advantages of safety, convenience, economy, small adverse reactions, and personalized treatment. Auricular therapy has the effect of treating constipation after stroke, and its mechanism may be related to stimulating the gastric region to help regulate the secretion of gastrointestinal hormones [13], improve vagal nerve excitability, promote colon smooth muscle movement, and improve gastrointestinal peristalsis [14]. A clinical study has shown that ear acupoint therapy can effectively promote the improvement of constipation symptoms after stroke, with faster results, especially in improving the time and frequency of first defecation [15].

When conducting systematic reviews and meta-analyses, the inclusion of RCTs is to minimize the impact of systemic bias. The design of RCTs can effectively reduce interference caused by other potential factors. This can more accurately evaluate the effectiveness of intervention measures. Meanwhile, the results of RCTs have wider applicability and can be promoted in different populations and trial conditions. Therefore, a systematic review and meta-analysis containing RCTs can provide more reliable and consistent evidence, making the results of the systematic review and meta-analysis more credible and providing more reliable guidance for decision-makers and clinical practice. Although RCTs are important in systematic reviews and meta-analyses, we also need to recognize that other types of study designs have their unique advantages and application areas. Sometimes, when there are no RCTs available, it is also necessary to consider including non randomized studies for a systematic review and meta-analysis of intervention effects. For example, for diseases with a very regular disease process and significant intervention effects, there is no need to conduct RCTs, such as penicillin anti-infection treatment, as there are currently no RCTs with definite therapeutic effects. In certain surgical fields, conducting randomized trials for therapeutic or psychological interventions also violates ethical principles. When evaluating non randomized studies, attention should be paid to avoiding confounding bias and publication bias. The study of etiology or risk factors usually adopts an observational study design, such as case-control studies or cohort studies. When conducting systematic reviews and meta-analyses, researchers will comprehensively consider different types of research designs based on the characteristics and objectives of the research, and provide reasonable explanations and generalizations of the results. The more restrictions the evaluator has on the design type selected for a certain problem, the more limited the data they can collect. However, if the selected research cannot provide reliable information to answer the questions raised, such a systematic review may be useless and even lead to misleading conclusions. Therefore, our protocol is to only include RCTs for research.

Although multiple RCTs of auricular therapy as a treatment for post-stroke constipation have been reported to date, the cumulative evidence for its efficacy has not been systematically evaluated. This study will be the first systematic review of the efficacy of auricular therapy in patients with post-stroke constipation. In addition to providing evidence for the effectiveness and safety of the disease, this study will also analyze the limitations of research on auricular therapy for post-stroke constipation, such as the common issue of "researchers and journals should pay more attention to negative results", in order to provide reference for future clinical design and result analysis.

Supporting information

S1 Appendix. PRISMA-P (Preferred Reporting Items for Systematic review and Meta-Analysis Protocols) 2015 checklist: Recommended items to address in a systematic review protocol*.

(DOC)

pone.0298537.s001.doc (65.9KB, doc)

Abbreviations

BSFS

Bristol stool form score

CI

confidence intervals

GRADE

Grading of Recommendations Assessment, Development and Evaluation

MD

mean difference

OR

odds ratios

PAC-QOL

patient assessment of constipation quality of life questionnaire

PRISMA

Preferred Reporting Items for Systematic Reviews and Meta-Analysis Protocol

RR

relative risk

SBMs

spontaneous bowel movements

Data Availability

No datasets were generated or analysed during the current study. Deidentified research data will be made publicly available when the study is completed and published.

Funding Statement

This study was supported by Jilin Province Health Science and Technology Capacity Improvement Plan Project(NO.2021JC070) Changchun Science and Technology Development Project (NO.21ZGM32);Jilin Traditional Chinese Medicine Science and Technology Project in 2022(NO.2022036).All funds conflict-free.

References

  • 1.Putaala J. Ischemic Stroke in Young Adults. Continuum (Minneap Minn). 2020;26(2):386–414. doi: 10.1212/CON.0000000000000833 [DOI] [PubMed] [Google Scholar]
  • 2.Lin C J, Hung J W, Cho C Y, et al. Poststroke constipation in the rehabilitation ward: incidence, clinical course and associated factors. Singapore Med J. 2013;54(11):624–629. doi: 10.11622/smedj.2013222 [DOI] [PubMed] [Google Scholar]
  • 3.Li J, Yuan M, Liu Y, et al. Incidence of constipation in stroke patients: A systematic review and meta-analysis. Medicine (Baltimore). 2017;96(25):e7225. doi: 10.1097/MD.0000000000007225 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Wen J, Zhuang Z, Zhao M, et al. Treatment of poststroke constipation with moxibustion: A case report. Medicine (Baltimore). 2018;97(24):e11134. doi: 10.1097/MD.0000000000011134 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Ingeman A, Andersen G, Hundborg H H, et al. In-hospital medical complications, length of stay, and mortality among stroke unit patients. Stroke. 2011;42(11):3214–3218. doi: 10.1161/STROKEAHA.110.610881 [DOI] [PubMed] [Google Scholar]
  • 6.De Luca R, Maresca G, Balletta T, et al. Does overground robotic gait training improve non-motor outcomes in patients with chronic stroke? Findings from a pilot study. J Clin Neurosci. 2020;81:240–245. doi: 10.1016/j.jocn.2020.09.070 [DOI] [PubMed] [Google Scholar]
  • 7.Doshi V S, Say J H, Young S H, et al. Complications in stroke patients: a study carried out at the Rehabilitation Medicine Service, Changi General Hospital. Singapore Med J. 2003;44(12):643–652. [PubMed] [Google Scholar]
  • 8.Jin C, Jang B H, Jeon J P, et al. Traditional East Asian herbal medicines for the treatment of poststroke constipation: A protocol for systematic review and meta analysis. Medicine (Baltimore). 2021;100(15):e25503. doi: 10.1097/MD.0000000000025503 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Tang M, Feng S, Zhou Y, et al. Effectiveness and safety of auricular therapy for post-stroke depression: A protocol for systematic review and meta-analysis. Medicine (Baltimore). 2022;101(2):e28505. doi: 10.1097/MD.0000000000028505 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Shamseer L, Moher D, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. 2015;350:g7647. doi: 10.1136/bmj.g7647 [DOI] [PubMed] [Google Scholar]
  • 11.Higgins J P, Altman D G, Gotzsche P C, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928. doi: 10.1136/bmj.d5928 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Furness J B, Callaghan B P, Rivera L R, et al. The enteric nervous system and gastrointestinal innervation: integrated local and central control. Adv Exp Med Biol. 2014;817:39–71. doi: 10.1007/978-1-4939-0897-4_3 [DOI] [PubMed] [Google Scholar]
  • 13.Heping Hai, Guirong Wu, Suqin Wang. Effect and Mechanism of Ear Point Pressing on Preventing Poststroke Constipation. Chinese Journal of Clinical Nursing. 2014; 6(02):108–110.(chinese) [Google Scholar]
  • 14.Zhang Yiling. Study on the mechanism of ear acupuncture electrical stimulation in treating opioid induced constipation and brain intestinal axis in rats. Beijing University of Traditional Chinese Medicine. 221. (Chinese)
  • 15.Zhiyue Di. Observation on the effect of embedding seeds at ear points on constipation after stroke and its influence on serum SP and VIP levels. Heilongjiang University of Traditional Chinese Medicine, 2020. (Chinese) [Google Scholar]

Decision Letter 0

Md Shahjalal

11 Dec 2023

PONE-D-23-23599Efficacy and safety of auricular therapy in the treatment of Post-stroke constipation:A protocol for systematic review and meta-analysisPLOS ONE

Dear Dr. Zhao,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Jan 25 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Md. Shahjalal

Academic Editor

PLOS ONE

Additional Editor Comments (if provided):

Please make sure the method section is clearer and specific. 

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Does the manuscript provide a valid rationale for the proposed study, with clearly identified and justified research questions?

The research question outlined is expected to address a valid academic problem or topic and contribute to the base of knowledge in the field.

Reviewer #1: No

**********

2. Is the protocol technically sound and planned in a manner that will lead to a meaningful outcome and allow testing the stated hypotheses?

The manuscript should describe the methods in sufficient detail to prevent undisclosed flexibility in the experimental procedure or analysis pipeline, including sufficient outcome-neutral conditions (e.g. necessary controls, absence of floor or ceiling effects) to test the proposed hypotheses and a statistical power analysis where applicable. As there may be aspects of the methodology and analysis which can only be refined once the work is undertaken, authors should outline potential assumptions and explicitly describe what aspects of the proposed analyses, if any, are exploratory.

Reviewer #1: No

**********

3. Is the methodology feasible and described in sufficient detail to allow the work to be replicable?

Descriptions of methods and materials in the protocol should be reported in sufficient detail for another researcher to reproduce all experiments and analyses. The protocol should describe the appropriate controls, sample size calculations, and replication needed to ensure that the data are robust and reproducible.

Reviewer #1: No

**********

4. Have the authors described where all data underlying the findings will be made available when the study is complete?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception, at the time of publication. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: No

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above and, if applicable, provide comments about issues authors must address before this protocol can be accepted for publication. You may also include additional comments for the author, including concerns about research or publication ethics.

You may also provide optional suggestions and comments to authors that they might find helpful in planning their study.

(Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: This is a systematic review that aims to study the effectiveness and safety of auricular therapy for constipation of post-stroke. I have a few comments;

1. Why do you only include RCTs among the study designs?

2. Line 112: What is a non-standard Randomized controlled trial? Please correct R to r.

3. Line 114: Please correct Observational to observational.

4. Line 122: Why not include patients with subdural or subarachnoid hemorrhage?

5. 2.2.3. Types of interventions: Please describe auricular therapy in more detail.

6. 2.2.4. Types of outcome measures: I recommend that the primary outcome be an outcome commonly used in constipation studies.

7. 2.4.5 Please plan for subgroup analysis.

Overall, please double check spelling and spacing.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2024 Feb 26;19(2):e0298537. doi: 10.1371/journal.pone.0298537.r002

Author response to Decision Letter 0


27 Dec 2023

Dear Editors and Reviewers:

We gratefully thank the editor and all reviewers for their time spend making their constructive remarks and useful suggestions, which has significantly raised the quality of the manuscript and has enable us to improve the manuscript. Each suggested revision and comment, brought forward by the reviewers was accurately incorporated and considered. Below the comments of the reviewers are response point by point and the revisions are indicated.

Responds to the reviewer’s comments:

Reviewer #1:

1.Comment:Why do you only include RCTs among the study designs?

1.Reply:When conducting systematic reviews and meta-analyses, the inclusion of RCTs is to minimize the impact of systemic bias. The design of RCTs can effectively reduce interference caused by other potential factors. This can more accurately evaluate the effectiveness of intervention measures. Meanwhile, the results of RCTs have wider applicability and can be promoted in different populations and trial conditions. Therefore, a systematic review and meta-analysis containing RCTs can provide more reliable and consistent evidence, making the results of the systematic review and meta-analysis more credible and providing more reliable guidance for decision-makers and clinical practice.

Although RCTs are important in systematic reviews and meta-analyses, we also need to recognize that other types of study designs have their unique advantages and application areas. Sometimes, when there are no RCTs available, it is also necessary to consider including non randomized studies for a systematic review and meta-analysis of intervention effects. For example, for diseases with a very regular disease process and significant intervention effects, there is no need to conduct RCTs, such as penicillin anti-infection treatment, as there are currently no RCTs with definite therapeutic effects. In certain surgical fields, conducting randomized trials for therapeutic or psychological interventions also violates ethical principles. When evaluating non randomized studies, attention should be paid to avoiding confounding bias and publication bias. The study of etiology or risk factors usually adopts an observational study design, such as case-control studies or cohort studies. When conducting systematic reviews and meta-analyses, researchers will comprehensively consider different types of research designs based on the characteristics and objectives of the research, and provide reasonable explanations and generalizations of the results.

The more restrictions the evaluator has on the design type selected for a certain problem, the more limited the data they can collect. However, if the selected research cannot provide reliable information to answer the questions raised, such a systematic review may be useless and even lead to misleading conclusions. Therefore, our protocol is to only include RCTs for research.

At the same time, we will also include this part in the discussion of the paper to increase the completeness of the discussion. Please see page 12 of the revised manuscript, lines 239-249, and page 13, lines 250-266.

2.Comment:Line 112: What is a non-standard Randomized controlled trial? Please correct R to r.

2.Reply:We thank the reviewer for pointing this out. This is a typo. We have changed "Non standard randomized controlled trial" to "Quasi-RCTs" in the text. Please see page 5 of the revised manuscript, lines 110.

3.Comment:Line 114:Please correct Observational to observational.

3.Reply:We thank the reviewer for pointing this out. We have changed "Observational" to "observational" in the text. Please see page 6 of the revised manuscript, lines 111.

4.Comment:Line 122:Why not include patients with subdural or subarachnoid hemorrhage?

4.Reply:The commonly referred stroke refers to a condition caused by cerebral ischemia or cerebral hemorrhage. Subdural or subarachnoid hemorrhage is a special type of cerebrovascular disease, and its causes are different from those of stroke. Subarachnoid hemorrhage refers to the rupture of cerebral aneurysms, brain trauma, or other causes that lead to the rupture of cerebral blood vessels and the entry of blood into the subarachnoid space. In this case, blood can compress brain tissue and cause severe neurological symptoms. Subdural hemorrhage refers to the bleeding between the dura mater and the arachnoid membrane, which is commonly seen in the rupture of cortical arteries or veins at the site of cerebral contusion, or in the formation of cerebral hematoma penetrating the cortex and into the subdural space.

Due to the differences in pathogenesis and clinical manifestations between subdural or subarachnoid hemorrhage and other types of stroke, it may be necessary to study its related complications and sequelae separately, including constipation. Therefore, in systematic reviews and meta-analyses of post-stroke constipation, cerebral infarction and cerebral hemorrhage are usually the main focus, and cases of subdural or subarachnoid hemorrage are not included. This can make the research results more targeted and comparable.

5.Comment:2.2.3.Types of interventions: Please describe auricular therapy in more detail.

5.Reply:We thank the reviewer for pointing this out. Auricular therapy is a method for treating by stimulating a specific point in the ear, including medicine beans or magnetic beads, acupuncture, electroacupuncture, acupressure, drug injection, electric pulse stimulation, moxibustion, auricle bloodletting, etc. We have revised the text to address your concerns and hope that it is now clearer. Please see page 6 of the revised manuscript, lines 124-127.

6.Comment:2.2.4.Types of outcome measures: I recommend that the primary outcome be an outcome commonly used in constipation studies.

6.Reply:We thank the reviewer for pointing this out. For the primary outcome, we will assess the frequency of spontaneous defecation, defined as the mean number of spontaneous defecations per week. We have revised the text to address your concerns and hope that it is now clearer. Please see page 6 of the revised manuscript, lines 132, and page 7, lines 133.

7.Comment:2.4.5 Please plan for subgroup analysis.

7.Reply:We thank the reviewer for pointing this out. We will perform subgroup analysis based on age, gender, type of stroke (hemorrhagic and ischemic stroke), different definitions of constipation, stages of stroke (acute, subacute or chronic), and controls Type of group (placebo, no treatment or other active treatment or medication). A subgroup analysis based on different dietary groups takes into account that eating habits mayplay a role,and habits are playing an important role in the development of constipation. The intervention effect was analyzed using the χ2 test, with p<0.05, indicating a statistically significant difference between the subgroups. We have revised the text to address your concerns and hope that it is now clearer. Please see page 10 of the revised manuscript, lines 201-205, and page 11, lines 206-209.

At the same time, we have also made corresponding modifications to the spelling and spacing issues raised by the reviewers.

We would like to thank the referee again for taking the time to review our manuscript.

Attachment

Submitted filename: Response to reviewers.docx

pone.0298537.s002.docx (14.3KB, docx)

Decision Letter 1

Md Shahjalal

26 Jan 2024

Efficacy and safety of auricular therapy in the treatment of Post-stroke constipation: A protocol for systematic review and meta-analysis

PONE-D-23-23599R1

Dear Dr. Dexi Zhao,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Md. Shahjalal

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Dear authors,

Thank you for pint by point response.

Please make sure same reference style and PLoS ONE guidelines.

Wish you the best.

Reviewers' comments:

Acceptance letter

Md Shahjalal

16 Feb 2024

PONE-D-23-23599R1

PLOS ONE

Dear Dr. Zhao,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Md. Shahjalal

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Appendix. PRISMA-P (Preferred Reporting Items for Systematic review and Meta-Analysis Protocols) 2015 checklist: Recommended items to address in a systematic review protocol*.

    (DOC)

    pone.0298537.s001.doc (65.9KB, doc)
    Attachment

    Submitted filename: Response to reviewers.docx

    pone.0298537.s002.docx (14.3KB, docx)

    Data Availability Statement

    No datasets were generated or analysed during the current study. Deidentified research data will be made publicly available when the study is completed and published.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES